CIK 0001724521
- Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473898435
- Phone
- +1 510-694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-23 | Markus Richard Chief Medical Officer | Grant or award | +24,000 | 89,647 | ||
| 2026-01-23 | Markus Richard Chief Medical Officer | Grant or award · Stock Option (right to buy) | +96,000 | 96,000 | ||
| 2025-12-17 | Markus Richard Chief Medical Officer | Sale 10b5-1 | −4,494 | $22.16 | $100K | 65,647 |
| 2025-12-16 | Markus Richard Chief Medical Officer | Sale 10b5-1 | −5,052 | $21.88 | $111K | 70,141 |
| 2025-02-10 | Markus Richard Chief Medical Officer | Grant or award | +75,193 | 75,193 | ||
| 2025-02-10 | Markus Richard Chief Medical Officer | Grant or award · Stock Option (right to buy) | +305,328 | 305,328 |
Page 1 of 1 · 6 trades